Tag: Candel Therapeutics Inc.

Stock Earnings

Investing in Candel Therapeutics Inc (CADL) Is Getting More Attractive

Candel Therapeutics Inc’s filing revealed that its Chief Medical Officer Nichols William Garrett unloaded Company’s shares for reported $0.4 million

Analysts Viewpoint

Chief Medical Officer Nichols William Garrett sold 45,316 shares of Candel Therapeutics Inc [CADL]

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Insiders Updates

Candel Therapeutics Inc [CADL] Chief Medical Officer makes an insider sale of 45,316 shares worth $0.4 million.

Candel Therapeutics Inc’s recent filing unveils that its Chief Medical Officer Nichols William Garrett unloaded Company’s shares for reported $0.4

Stock Earnings

A company insider recently sold 31,278 shares of Candel Therapeutics Inc [CADL]. Should You Sale?

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Stock Earnings

A Guide To The Risks Of Investing In Candel Therapeutics Inc (CADL)

Candel Therapeutics Inc’s recent filing unveils that its Chief Scientific Officer Barone Francesca unloaded Company’s shares for reported $97783.0 on

Stock Earnings

Selling Buzz: Candel Therapeutics Inc [CADL] Chief Scientific Officer Barone Francesca sells 13,534 shares of the company

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Stock Earnings

A company insider recently sold 13,534 shares of Candel Therapeutics Inc [CADL]. Should You also Consider to Sale?

Candel Therapeutics Inc’s filing revealed that its Chief Scientific Officer Barone Francesca unloaded Company’s shares for reported $97783.0 on Jan

Analysts Viewpoint

Candel Therapeutics Inc [CADL] Records 50-Day SMA of $8.36

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

Insider Sale Alert: Candel Therapeutics Inc [CADL] – Is it Time to sell?

Candel Therapeutics Inc’s filing revealed that its Chief Scientific Officer Barone Francesca unloaded Company’s shares for reported $97783.0 on Jan